Osaic Holdings
DTIL icon

Osaic Holdings’s Precision BioSciences DTIL Stock Holding History

Osaic Holdings’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$730 Buy
93
+75
+417% +$528 ﹤0.01% 7571
2026
Q1 		$99 Sell
18
-73
-80% -$337 ﹤0.01% 7629
2025
Q4 		$378 Hold
91
– – ﹤0.01% 7488
2025
Q3 		$491 Buy
91
+16
+21% +$77 ﹤0.01% 7551
2025
Q2 		$315 Buy
+75
New +$370 ﹤0.01% 7442
2025
Q1 		– Sell
-1,272
Closed -$4.84K – 7511
2024
Q4 		$4.84K Sell
1,272
-1,085
-46% -$7.92K ﹤0.01% 6213
2024
Q3 		$21.1K Buy
2,357
+200
+9% +$1.93K ﹤0.01% 5357
2024
Q2 		$21K Buy
2,157
+262
+14% +$3.09K ﹤0.01% 5312
2024
Q1 		$25.7K Buy
1,895
+403
+27% +$4.93K ﹤0.01% 5194
2023
Q4 		$16.3K Buy
1,492
+315
+27% +$3.4K ﹤0.01% 5597
2023
Q3 		$12.1K Sell
1,177
-33
-3% -$507 ﹤0.01% 5823
2023
Q2 		$19.1K Sell
1,210
-47
-4% -$1.07K ﹤0.01% 5593
2023
Q1 		$28.4K Buy
1,257
+38
+3% +$1.25K ﹤0.01% 5351
2022
Q4 		$44.4K Buy
1,219
+1,052
+630% +$41.6K ﹤0.01% 5022
2022
Q3 		$7K Sell
167
-7
-4% -$333 ﹤0.01% 6177
2022
Q2 		$8K Sell
174
-306
-64% -$18K ﹤0.01% 6226
2022
Q1 		$45K Sell
480
-52
-10% -$7.07K ﹤0.01% 5169
2021
Q4 		$119K Buy
532
+233
+78% +$65.1K ﹤0.01% 4432
2021
Q3 		$104K Sell
299
-34
-10% -$11.5K ﹤0.01% 4493
2021
Q2 		$125K Buy
333
+92
+38% +$27.6K ﹤0.01% 4283
2021
Q1 		$75K Buy
241
+109
+83% +$38.2K ﹤0.01% 4571
2020
Q4 		$33K Buy
132
+82
+164% +$20.1K ﹤0.01% 4845
2020
Q3 		$9K Buy
50
+33
+194% +$6.56K ﹤0.01% 5318
2020
Q2 		$4K Hold
17
– – ﹤0.01% 5552
2020
Q1 		$3K Buy
+17
New +$4.45K ﹤0.01% 5527

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Osaic Holdings's DTIL Position: Q2 2026 in Review

Osaic Holdings increased its Precision BioSciences (DTIL) stake by 417% in Q2 2026, buying an estimated $528 and bringing the position to 93 shares worth $730. The position accounts for ﹤0.01% of the portfolio, ranked #7571.

Osaic Holdings first reported a position in DTIL in Q1 2020 and has held it in 25 quarters since. The position peaked at $125K in Q2 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Osaic Holdings held 93 shares of Precision BioSciences worth $730 as of Q2 2026.
  • Osaic Holdings bought 75 Precision BioSciences shares in Q2 2026, an estimated $528.
  • Precision BioSciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7571 holding.
  • Osaic Holdings first reported a position in Precision BioSciences in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Precision BioSciences position peaked at $125K in Q2 2021.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.